ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |
| WASATCH ADVISORS LP | 11,526,100 | $11,295,578 | 0.07% |
| Bellevue Group AG | 4,204,264 | $4,120,179 | 0.07% |
| NJ State Employees Deferred Compensation Plan | 195,125 | $191,223 | 0.03% |
| SILVERBACK ASSET MANAGEMENT LLC | 100,000 | $197,672 | 0.03% |
| Virtu Financial LLC | 181,597 | $178 | 0.02% |
| Parallel Advisors, LLC | 478,000 | $468,440 | 0.02% |
| UBS OCONNOR LLC | 631,947 | $619,308 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 29,256 | $29 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,264,359 | $2,219,072 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 254,265 | $249,180 | 0.01% |
External links
This page lists ESPERION THERAPEUTICS INC NE's shareholders in Q3 2023. To view ESPERION THERAPEUTICS INC NE's shareholder history, click here.